Cloning and characterization of cDNAs encoding the complete sequence of decay-accelerating factor of human complement - PubMed (original) (raw)
Cloning and characterization of cDNAs encoding the complete sequence of decay-accelerating factor of human complement
M E Medof et al. Proc Natl Acad Sci U S A. 1987 Apr.
Abstract
cDNAs encoding the complement decay-accelerating factor (DAF) were isolated from HeLa and differentiated HL-60 lambda gt cDNA libraries by screening with a codon preference oligonucleotide corresponding to DAF NH2-terminal amino acids 3-14. The composite cDNA sequence showed a 347-amino acid protein preceded by an NH2-terminal leader peptide sequence. The translated sequence beginning at the DAF NH2 terminus encodes four contiguous approximately equal to 61-amino acid long repetitive units of internal homology. The repetitive regions contain four conserved cysteines, one proline, one glycine, one glycine/alanine, four leucines/isoleucines/valines, one serine, three tyrosines/phenylalanines, and one tryptophan and show striking homology to similar regions previously identified in factor B, C2, C4 binding protein, factor H, C1r, factor XIII, interleukin 2 receptor, and serum beta 2-glycoprotein I. The consensus repeats are attached to a 70-amino acid long segment rich in serine and threonine (potential O-glycosylation sites), which is in turn followed by a stretch of hydrophobic amino acids. RNA blot analysis of HeLa and HL-60 RNA revealed three DAF mRNA species of 3.1, 2.7, and 2.0 kilobases. The results indicate that portions of the DAF gene may have evolved from a DNA element common to the above proteins, that DAF cDNA predicts a COOH-terminal anchoring polypeptide, and that distinct species of DAF message are elaborated in cells.
Similar articles
- Pigs express multiple forms of decay-accelerating factor (CD55), all of which contain only three short consensus repeats.
Pérez de la Lastra JM, Harris CL, Hinchliffe SJ, Holt DS, Rushmere NK, Morgan BP. Pérez de la Lastra JM, et al. J Immunol. 2000 Sep 1;165(5):2563-73. doi: 10.4049/jimmunol.165.5.2563. J Immunol. 2000. PMID: 10946283 - Cloning of decay-accelerating factor suggests novel use of splicing to generate two proteins.
Caras IW, Davitz MA, Rhee L, Weddell G, Martin DW Jr, Nussenzweig V. Caras IW, et al. Nature. 1987 Feb 5-11;325(6104):545-9. doi: 10.1038/325545a0. Nature. 1987. PMID: 2433596 - Characterization of the decay-accelerating factor gene promoter region.
Ewulonu UK, Ravi L, Medof ME. Ewulonu UK, et al. Proc Natl Acad Sci U S A. 1991 Jun 1;88(11):4675-9. doi: 10.1073/pnas.88.11.4675. Proc Natl Acad Sci U S A. 1991. PMID: 1711208 Free PMC article. - Structure of the gene for human complement protein decay accelerating factor.
Post TW, Arce MA, Liszewski MK, Thompson ES, Atkinson JP, Lublin DM. Post TW, et al. J Immunol. 1990 Jan 15;144(2):740-4. J Immunol. 1990. PMID: 1688584
Cited by
- CD55 in cancer: Complementing functions in a non-canonical manner.
Bharti R, Dey G, Lin F, Lathia J, Reizes O. Bharti R, et al. Cancer Lett. 2022 Dec 28;551:215935. doi: 10.1016/j.canlet.2022.215935. Epub 2022 Oct 7. Cancer Lett. 2022. PMID: 36216147 Free PMC article. Review. - GPI-AP: Unraveling a New Class of Malignancy Mediators and Potential Immunotherapy Targets.
Hussein NH, Amin NS, El Tayebi HM. Hussein NH, et al. Front Oncol. 2020 Dec 4;10:537311. doi: 10.3389/fonc.2020.537311. eCollection 2020. Front Oncol. 2020. PMID: 33344222 Free PMC article. Review. - Discrete populations of isotype-switched memory B lymphocytes are maintained in murine spleen and bone marrow.
Riedel R, Addo R, Ferreira-Gomes M, Heinz GA, Heinrich F, Kummer J, Greiff V, Schulz D, Klaeden C, Cornelis R, Menzel U, Kröger S, Stervbo U, Köhler R, Haftmann C, Kühnel S, Lehmann K, Maschmeyer P, McGrath M, Naundorf S, Hahne S, Sercan-Alp Ö, Siracusa F, Stefanowski J, Weber M, Westendorf K, Zimmermann J, Hauser AE, Reddy ST, Durek P, Chang HD, Mashreghi MF, Radbruch A. Riedel R, et al. Nat Commun. 2020 May 22;11(1):2570. doi: 10.1038/s41467-020-16464-6. Nat Commun. 2020. PMID: 32444631 Free PMC article. - Engineered mRNA-expressed antibodies prevent respiratory syncytial virus infection.
Tiwari PM, Vanover D, Lindsay KE, Bawage SS, Kirschman JL, Bhosle S, Lifland AW, Zurla C, Santangelo PJ. Tiwari PM, et al. Nat Commun. 2018 Oct 1;9(1):3999. doi: 10.1038/s41467-018-06508-3. Nat Commun. 2018. PMID: 30275522 Free PMC article. - DAF in diabetic patients is subject to glycation/inactivation at its active site residues.
Flückiger R, Cocuzzi E, Nagaraj RH, Shoham M, Kern TS, Medof ME. Flückiger R, et al. Mol Immunol. 2018 Jan;93:246-252. doi: 10.1016/j.molimm.2017.06.036. Epub 2017 Sep 5. Mol Immunol. 2018. PMID: 28886871 Free PMC article.
References
- Proc Natl Acad Sci U S A. 1983 Nov;80(22):6947-51 - PubMed
- Biochemistry. 1986 Nov 4;25(22):6740-7 - PubMed
- Gene. 1983 Nov;25(2-3):263-9 - PubMed
- Nature. 1984 Jan 19-25;307(5948):237-41 - PubMed
- J Exp Med. 1984 Nov 1;160(5):1558-78 - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Molecular Biology Databases
Miscellaneous